EE9900315A - Pürrolo[3,4-d]pürimidinooni derivaadid ja nende kasutamine ravimitena - Google Patents
Pürrolo[3,4-d]pürimidinooni derivaadid ja nende kasutamine ravimitenaInfo
- Publication number
- EE9900315A EE9900315A EEP199900315A EE9900315A EE9900315A EE 9900315 A EE9900315 A EE 9900315A EE P199900315 A EEP199900315 A EE P199900315A EE 9900315 A EE9900315 A EE 9900315A EE 9900315 A EE9900315 A EE 9900315A
- Authority
- EE
- Estonia
- Prior art keywords
- pct
- pyrrolo
- medicaments
- sec
- pyrimidinone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9626643.2A GB9626643D0 (en) | 1996-12-21 | 1996-12-21 | Compounds |
PCT/SE1997/002157 WO1998028301A1 (en) | 1996-12-21 | 1997-12-18 | Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
EE9900315A true EE9900315A (et) | 2000-02-15 |
Family
ID=10804862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP199900315A EE9900315A (et) | 1996-12-21 | 1997-12-18 | Pürrolo[3,4-d]pürimidinooni derivaadid ja nende kasutamine ravimitena |
Country Status (23)
Country | Link |
---|---|
US (8) | US6046204A (tr) |
EP (1) | EP0946562B1 (tr) |
JP (1) | JP2001507687A (tr) |
KR (1) | KR20000069605A (tr) |
CN (1) | CN1246119A (tr) |
AT (1) | ATE215088T1 (tr) |
AU (1) | AU717429B2 (tr) |
BR (1) | BR9714063A (tr) |
CA (1) | CA2275312A1 (tr) |
CZ (1) | CZ289925B6 (tr) |
DE (1) | DE69711430T2 (tr) |
EE (1) | EE9900315A (tr) |
GB (1) | GB9626643D0 (tr) |
HU (1) | HUP0002839A3 (tr) |
ID (1) | ID21682A (tr) |
IL (1) | IL130538A0 (tr) |
IS (1) | IS5082A (tr) |
NO (1) | NO993027L (tr) |
NZ (1) | NZ336124A (tr) |
PL (1) | PL334228A1 (tr) |
SK (1) | SK76699A3 (tr) |
TR (1) | TR199901433T2 (tr) |
WO (1) | WO1998028301A1 (tr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9801399D0 (sv) | 1998-04-21 | 1998-04-21 | Astra Pharma Prod | Method and apparatus for filling containers |
ATE294793T1 (de) | 1999-01-15 | 2005-05-15 | Altana Pharma Ag | Phenantrhridin-n-oxides mit pde-iv hemmender wirkung |
AU2107700A (en) | 1999-01-15 | 2000-08-01 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridine-n-oxides with pde-iv inhibiting activity |
DE60033918D1 (de) | 1999-01-15 | 2007-04-26 | Altana Pharma Ag | Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung |
US6361486B1 (en) * | 2000-02-29 | 2002-03-26 | Agilent Technologies, Inc. | Coaxial-drive centrifuge providing tilt control relative to centrifugal force |
US20070105841A1 (en) * | 2000-08-14 | 2007-05-10 | Breitenbucher J G | Method for treating allergies using substituted pyrazoles |
CN1329392C (zh) * | 2000-08-14 | 2007-08-01 | 奥索-麦克尼尔药品公司 | 取代的吡唑 |
TW200407315A (en) * | 2002-04-23 | 2004-05-16 | Sankyo Co | Pyrimidine derivatives |
ES2546329T3 (es) * | 2003-07-24 | 2015-09-22 | Tecomet Inc. | Espumas no aleatorias ensambladas |
CA2571710A1 (en) | 2004-06-24 | 2006-11-02 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
MY140748A (en) | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
US8198288B2 (en) | 2006-05-04 | 2012-06-12 | Pulmagen Therapeutics (Inflammation) Limited | Tetrahydropyrrolopyrimidinediones and their use in therapy |
WO2007129060A1 (en) | 2006-05-04 | 2007-11-15 | Argenta Discovery Limited | Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
EP2023729B1 (en) | 2006-06-06 | 2016-05-04 | Intra-Cellular Therapies, Inc. | Organic compounds |
CN101969774A (zh) | 2007-12-06 | 2011-02-09 | 细胞内治疗公司 | 有机化合物 |
WO2009100403A1 (en) * | 2008-02-07 | 2009-08-13 | Neurogen Corporation | Substituted aryl pyrimidinones |
WO2010065153A1 (en) | 2008-12-06 | 2010-06-10 | Intra-Cellular Therapies, Inc. | Organic compounds |
CA2740396A1 (en) | 2008-12-06 | 2010-06-10 | Intra-Cellular Therapies, Inc. | Organic compounds |
US8927556B2 (en) * | 2008-12-06 | 2015-01-06 | Intra-Cellular Therapies, Inc. | 1H-pyrrolo[3,4-D]pyrimidin-2(6H)-one compounds |
IN2012DN00719A (tr) * | 2009-08-10 | 2015-06-19 | Univ California | |
WO2011153136A1 (en) | 2010-05-31 | 2011-12-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
WO2011153135A1 (en) | 2010-05-31 | 2011-12-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
USRE48842E1 (en) | 2011-05-27 | 2021-12-07 | The Regents Of The University Of California | Pyrimido-pyrrolo-oxazine-dione compound inhibitors of the cystic fibrosis transmembrane conductance regulator protein and uses therefor |
US9546175B2 (en) | 2014-08-07 | 2017-01-17 | Intra-Cellular Therapies, Inc. | Organic compounds |
CN108129486B (zh) * | 2018-01-25 | 2020-06-05 | 华东理工大学 | 嘧啶酮衍生物及其用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993004047A1 (en) * | 1991-08-16 | 1993-03-04 | Merck & Co., Inc. | Quinazoline derivatives as inhibitors of hiv reverse transcriptase |
GB9424842D0 (en) * | 1994-12-09 | 1995-02-08 | British Tech Group | Pharmaceutical compositions |
-
1996
- 1996-12-21 GB GBGB9626643.2A patent/GB9626643D0/en active Pending
-
1997
- 1997-12-18 ID IDW990507A patent/ID21682A/id unknown
- 1997-12-18 CZ CZ19992204A patent/CZ289925B6/cs not_active IP Right Cessation
- 1997-12-18 NZ NZ336124A patent/NZ336124A/en unknown
- 1997-12-18 US US09/011,780 patent/US6046204A/en not_active Expired - Fee Related
- 1997-12-18 DE DE69711430T patent/DE69711430T2/de not_active Expired - Fee Related
- 1997-12-18 CN CN97181811A patent/CN1246119A/zh active Pending
- 1997-12-18 IL IL13053897A patent/IL130538A0/xx unknown
- 1997-12-18 JP JP52869798A patent/JP2001507687A/ja not_active Ceased
- 1997-12-18 AT AT97952146T patent/ATE215088T1/de active
- 1997-12-18 PL PL97334228A patent/PL334228A1/xx unknown
- 1997-12-18 EP EP97952146A patent/EP0946562B1/en not_active Expired - Lifetime
- 1997-12-18 WO PCT/SE1997/002157 patent/WO1998028301A1/en not_active Application Discontinuation
- 1997-12-18 BR BR9714063-5A patent/BR9714063A/pt not_active IP Right Cessation
- 1997-12-18 TR TR1999/01433T patent/TR199901433T2/tr unknown
- 1997-12-18 SK SK766-99A patent/SK76699A3/sk unknown
- 1997-12-18 HU HU0002839A patent/HUP0002839A3/hu unknown
- 1997-12-18 CA CA002275312A patent/CA2275312A1/en not_active Abandoned
- 1997-12-18 AU AU55809/98A patent/AU717429B2/en not_active Ceased
- 1997-12-18 KR KR1019997005595A patent/KR20000069605A/ko not_active Application Discontinuation
- 1997-12-18 EE EEP199900315A patent/EE9900315A/xx unknown
-
1999
- 1999-06-14 IS IS5082A patent/IS5082A/is unknown
- 1999-06-18 NO NO993027A patent/NO993027L/no not_active Application Discontinuation
-
2000
- 2000-02-17 US US09/505,857 patent/US6136974A/en not_active Expired - Fee Related
- 2000-02-17 US US09/506,091 patent/US6229013B1/en not_active Expired - Fee Related
- 2000-02-17 US US09/505,862 patent/US6211368B1/en not_active Expired - Fee Related
- 2000-02-17 US US09/506,090 patent/US6166206A/en not_active Expired - Fee Related
- 2000-11-08 US US09/707,880 patent/US6306863B1/en not_active Expired - Fee Related
-
2001
- 2001-10-09 US US09/971,709 patent/US20020025966A1/en not_active Abandoned
-
2003
- 2003-03-05 US US10/378,913 patent/US20030162798A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE9900315A (et) | Pürrolo[3,4-d]pürimidinooni derivaadid ja nende kasutamine ravimitena | |
SE9701398D0 (sv) | Novel compounds | |
EE200000318A (et) | Uudsed ühendid | |
SE9702772D0 (sv) | Novel compounds | |
TR200000197T2 (tr) | Yeni bileşimler | |
BR9609617B1 (pt) | derivados de 7h-pirrol[2,3-d]pirimidina, e composição farmacêutica. | |
HUT70505A (en) | Pyrrolo[2,3-d]pyrimidine derivatives, pharmaceutical compositions containing them and process for preparing them | |
EE04018B1 (et) | Tieno[2,3-d]pürimidiindioonid, nende valmistamisemeetod ja neid sisaldavad ravimkoostised | |
DE69911785D1 (de) | Triazolo[4,5-d]pyrimidin-verbindungen | |
DE69804766D1 (de) | Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
AU1929688A (en) | Leukotriene antagonists, processes for the preparation thereof, the use thereof for the treatment of diseases, and precursors |